Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCash from Financing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

BioCorRx (BICX) Amortizatization of Intangibles (2016 - 2025)

Historic Amortizatization of Intangibles for BioCorRx (BICX) over the last 14 years, with Q3 2025 value amounting to -$22781.0.

  • BioCorRx's Amortizatization of Intangibles rose 9383.21% to -$22781.0 in Q3 2025 from the same period last year, while for Sep 2025 it was $598668.0, marking a year-over-year increase of 35095.7%. This contributed to the annual value of $621506.0 for FY2024, which is 25898.64% up from last year.
  • Latest data reveals that BioCorRx reported Amortizatization of Intangibles of -$22781.0 as of Q3 2025, which was up 9383.21% from $1324.0 recorded in Q2 2025.
  • BioCorRx's Amortizatization of Intangibles' 5-year high stood at $568927.0 during Q4 2024, with a 5-year trough of -$369346.0 in Q3 2024.
  • Its 5-year average for Amortizatization of Intangibles is $54921.3, with a median of $28917.0 in 2022.
  • The largest annual percentage gain for BioCorRx's Amortizatization of Intangibles in the last 5 years was 69483.44% (2024), contrasted with its biggest fall of 126538.67% (2024).
  • Quarter analysis of 5 years shows BioCorRx's Amortizatization of Intangibles stood at $27109.0 in 2021, then rose by 9.44% to $29667.0 in 2022, then soared by 170.25% to $80176.0 in 2023, then skyrocketed by 609.6% to $568927.0 in 2024, then plummeted by 104.0% to -$22781.0 in 2025.
  • Its Amortizatization of Intangibles was -$22781.0 in Q3 2025, compared to $1324.0 in Q2 2025 and $51198.0 in Q1 2025.